PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34499887-4	2021	PPARalpha mRNA and protein levels decreased whereas ANGPTL3 mRNA and protein levels increased in a time-dependent manner in podocytes treated with puromycin aminonucleoside (PAN).	Puromycin Aminonucleoside	147-172	peroxisome proliferator activated receptor alpha	Mus musculus	0-9	
34499887-4	2021	PPARalpha mRNA and protein levels decreased whereas ANGPTL3 mRNA and protein levels increased in a time-dependent manner in podocytes treated with puromycin aminonucleoside (PAN).	Puromycin Aminonucleoside	147-172	angiopoietin-like 3	Mus musculus	52-59	
34499887-5	2021	Gemfibrozil, a pharmacological agonist of PPARalpha, increased PPARalpha levels and activity in podocytes.	Gemfibrozil	0-11	peroxisome proliferator activated receptor alpha	Mus musculus	42-51	
34499887-5	2021	Gemfibrozil, a pharmacological agonist of PPARalpha, increased PPARalpha levels and activity in podocytes.	Gemfibrozil	0-11	peroxisome proliferator activated receptor alpha	Mus musculus	63-72	
34499887-11	2021	This study identified a novel mechanism of the PPARalpha agonist gemfibrozil that exerts its protective effects by inhibiting PAN-induced apoptosis and cytoskeleton rearrangements through inhibition of ANGPTL3 expression.	Gemfibrozil	65-76	peroxisome proliferator activated receptor alpha	Mus musculus	47-56	
34499887-11	2021	This study identified a novel mechanism of the PPARalpha agonist gemfibrozil that exerts its protective effects by inhibiting PAN-induced apoptosis and cytoskeleton rearrangements through inhibition of ANGPTL3 expression.	Gemfibrozil	65-76	angiopoietin-like 3	Mus musculus	202-209